Table 2 CT findings in COVID-19 patients
From: CT characteristics and laboratory findings of COVID-19 pneumonia in relation to patient outcome
Total (N = 164) | N = 120 (excluding the normal cases) | |
|---|---|---|
GGO | 118 (72%) | 118 (98.3%) |
Multifocal | 109 (66.5%) | 109 (90.8%) |
Distribution | ||
Peripheral | 86 (52.4%) | 86 (71.7%) |
Diffuse | 34 (20.7%) | 34 (28.3%) |
Consolidation | 52 (31.7%) | 52 (43.3%) |
Septal thickening | 41 (25%) | 41 (34.2%) |
Crazy paving | 9 (5.5%) | 9 (7.5%) |
Reverse halo | 3 (1.8%) | 3 (2.5%) |
Nodules | 4 (2.4%) | 4 (3.3%) |
Lymphadenopathy | 6 (3.6%) | 6 (5%) |
Pleural effusion | 0 (0%) | 0 (0%) |